This tiny weight loss drug stock is going nuts 🥜

Today’s big movers inside                                                                                                                                                                                                                                                                                                                                                                                                                 May 29, 2024 | [Read Online]( This tiny weight loss drug stock is going nuts 🥜 *sponsored by Shore Thing Media Good morning, 360! Join Jason Bond TODAY for a special LIVE session – he’s continuing to CRUSH it in [Small Account Journey]( & has a new $2K Challenge starting Monday. [Be in THIS ROOM today @2pm EST.]( FOCUS LIST🔎 SYTA - Up over 80% in the pre-market after announcing yesterday that its SD7 PTT handsets had been selected by a Public Utility to replace two-way radios SCPX - Up over 38% in pre after reporting a 359% YoY increase in Q1 revenue   RSLS - Up over 80% in pre after significant increase in volume yesterday *sponsored by Shore Thing Media [Missed NVIDIA? Newly Listed Company Aims to Be the Future of AI Investment]( With a stake in the world’s fastest AI servers, this company is democratizing the AI landscape and generating millions in revenue in the process. “The Second AI Wave Is Forming,” according to Money & Markets. [>> Don’t miss this one!]( 🏄 *Sponsored content/paid advertisement. This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. HOTLIST🔥 SYTA - Up over 80% in the pre-market after announcing yesterday that its SD7 PTT handsets had been selected by a Public Utility to replace two-way radios Siyata Mobile Inc. develops and provides a cellular-based communications platform. It develops, markets, and sells rugged handheld Push-to-Talk over Cellular smartphone devices for first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in various industries. Late yesterday, the company announced that its SD7 PTT handsets had been selected by a Public Utility to replace two-way radios. It had received an order from the City of Lancaster Public Utilities Department for the headset the size of which was not disclosed. After being sold off heavily in recent months, the stock traded up over 80% in the pre-market this morning after the news yesterday. The $2.80 area acted as support in the pre-market and now becomes a potential resistance level. Above it, targets to the upside are $3 and then the pre-market high at $3.21. Beyond that, $3.50, $4 and $4.92 come into play. Below $2.80, targets to the downside are $2.63, $2.64, $2.20, $2, $1.80 and then a gap fill at $1.50. SCPX - Up over 38% in pre after reporting a 359% YoY increase in Q1 revenue Scorpius Holdings Inc. (SCPX) through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. In the after-hours yesterday, the company reported Q1 2024 financial results. Highlights include: Reduces operating expenses by 34% and net loss by 64% 359% Year-Over-Year Increase in Revenue Q1 2024 revenue from process development was $3.5 million vs $0.7 million a year prior. Net loss attributable to Scorpius was approximately $4.4 million, or ($0.16) per basic and diluted share in Q1 2024 vs $12.8 million, or ($0.49) per basic and diluted share, for Q1 2023. As of March 31, 2024, the Company had approximately $1.7 million in cash, cash equivalents, and short-term investments. On May 16, 2024, the Company consummated a public offering resulting in aggregate gross proceeds of approximately $6.0 million, before deducting underwriting discounts and other offering expenses. The stock traded up over 38% in the pre-market in reaction to the earnings report. The $0.15 area has acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $0.1650, $0.18, and then the pre-market high at $0.2069. Beyond that, $0.21, $0.2460, and $0.30 come into play. Below $0.15, targets to the downside are $0.12 and $0.10. New $2,000 Journey Starts Monday Jason’s Current Balance Going Strong +1,685% Winning 201/225 Trades *Trading is hard, results not guaranteed and should not be expected to be replicated typically. [Subscribe Now & Save 60% on Membership]( [CLICK HERE]( for LIVE TODAY @2pm EST RSLS - Up over 80% in pre after significant increase in volume yesterday ReShape Lifesciences Inc. (RSLS) provides products and services that manage and treat obesity and metabolic diseases in the United States and internationally. Despite no news yesterday, there was increased volume in trade yesterday in sympathy with Ozempic's 'miracle' weight loss craze. After the significant volume yesterday, the stock traded up another 80% in the pre-market this morning. The $0.40 area acted as support in the after-hours and will be an important level to watch. Above it, targets to the upside are $0.45, $0.50 and then the after-hours high at $0.5555. Beyond that, $0.60, $0.80, $0.90 and $1 come into play. Below $0.40, targets to the downside are $0.35, $0.30, and then a gap fill at $0.2078. MARKET NEWS 📰 👊 Make sure you are getting my mobile text alerts –  text “RAGE” to 1-(888) 404-5747 to get all of my latest HOT STOCK ideas delivered right to your phone (make sure you put the “1” at the front!). Don’t miss out! Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull *Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call “typical.” Just a quick heads up about this ad you're reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received five thousand dollars (cash) from Shore Thing Media for advertising ALSET CAPITAL INC for a four-day marketing program starting on May 28 and ending on May 31 of 2024. This amount was paid by someone else not connected to ALSET CAPITAL INC. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case. Now, diving right into ALSET CAPITAL INC might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r. Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now. Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1ties br0ker-dealer, br0ker, 1nvestment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry authority, or any self-regulat0ry organization. So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America